Search

1 to 10 of 419
Sort by


Web Page
6.1 Society for Immunotherapy of Cancer Celebrates Cancer Immunotherapy Month™

FOR IMMEDIATE RELEASE June 1, 2020 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to celebrate...


Library Entry
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce

As the field of cancer immunotherapy continues to advance at a fast pace, treatment approaches and drug development are evolving rapidly to maximize patient benefit. New agents are commonly evaluated for activity in patients who had previously received a programmed death receptor 1 (PD-1)...



Library Entry
Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit

Quality measures are important because they can help improve and standardize the delivery of cancer care among healthcare providers and across tumor types. In an environment characterized by a rapidly shifting immunotherapeutic landscape and lack of associated long-term outcome data, defining...


Web Page
2020 SITC Press Releases

Press Release Headline – Date Published Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Multiple Myeloma – 8/3/20 Oncology News Burst from FDA: Atezolizumab – 7/31/20 Oncology News Burst from FDA: Avelumab – 7/1/20 ...




Library Entry
2020 SITC Cancer Immunotherapy Winter School - Day 5 - Friday

The Society for Immunotherapy of Cancer (SITC) hosted the 2020 SITC Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program on January 13-17, 2020. Available here are the presentation slides and video from Friday, January 17, 2020. Program Organizers ...

8 attachments